Bi-weekly Member Newsletter                                                April 6, 2017

Keep up-to-date with the latest legislative and regulatory news. Click here for archived Capitol Connections newsletters. Send your suggestions and questions to
DQSA Coalition Update

  • U.S. Congressman Buddy Carter (R-GA) sent a letter on March 31st to Chairman Robert Aderholt and Ranking Member Sanford Bishop who serve on the Subcommittee on Agriculture, Rural Development, FDA and Related Agencies on the House Appropriations Committee. Click here.
  • U.S. Congressman Pete Olson (R-TX) is leading a letter to FDA regarding the Pharmacy Compounding Advisory Committee (PCAC). The letter emphasizes the importance of putting members with compounding experience on the PCAC! Will report future developments on this effort. 
  • The nomination hearing for Scott Gottlieb, MD, to serve as Commissioner of the Food & Drug Administration (FDA) occurred yesterday, and can be viewed here. IACP submitted a question regarding FDA's current regulatory outlook about compounding for Dr. Gottlieb's confirmation hearing which is being submitted as a Question for the Record (QFR).
We're Up to 50 Signatures! 

TAKE ACTION by May 1st! Ask your Representatives to Sign Letter to FDA 

Please contact your respective Congressional representatives, asking them to join Congressmen Stewart and Carter in signing a bipartisan communique to FDA! 

THANK YOU! To date, 410 messages have been sent to the Hill and 50 House signatures have been obtained! We are not publishing the signature list at this point. If you would like to know if your Representative has signed on, please email

Please note: Representative Stewart's office has  extended the signature deadline to Monday, May 1st. Please continue contacting your respective offices as we continue this campaign.

Let's try to get as many signatures as we can and send a strong message to FDA that the Agency must follow the 2016 Omnibus appropriations language!

IACP Featured in Inside Health Policy on Office-use

IACP's Executive Vice President John Voliva, RPh, discusses the importance of office-use compounding for patients in a recent interview with D.C.-based publication,  Inside Health Policy.

"John Voliva, executive vice president of the International Academy of Compounding Pharmacists, says the final guidance, 'Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act,' put limits on office-use compounding that go against congressional intent and should be rescinded.

"We're asking for FDA to rescind it. It would be administrative from that standpoint, and then issue a proposed rule through the [Administrative Procedure Act] so we have notice and comment from the stakeholders on the public docket," Voliva said to Inside Health Policy.

Click here to read the entire article.
Mylan Hit With New Class Action Lawsuit Over EpiPen Pricing - click here.
IACP Town Hall on April 12th! 

Save the Date for an IACP Town Hall on Wednesday, April 12th at 11:00 am CT

IACP's Executive Vice President John Voliva, RPh and the Government Affairs Team, Cynthia Blankenship and David Pore, will update you on recent D.C. efforts, the DQSA Coalition and the Rep. Stewart/Carter letter to FDA. Don't miss it!

Call-in instructions have been emailed and faxed to you.

Save the Date for Public Affairs Industry Partner Update on April 20th in Dallas

The next Public Affairs Industry Partner Update is in Dallas, Texas on April 20th!

Plan to attend as IACP, National Community Pharmacists Association and PCCA provide the latest legislative and regulatory news, and an update on efforts to protect your patients' access to compounded medications. Please click here for more information and to register.  
Are You Registered for CCH?

Congressman Buddy Carter (R-GA), the only pharmacist in the United States Congress, will be kicking off Compounders on Capitol Hill 2017!

A longtime champion of pharmacy compounding and a member of the Energy and Commerce Committee, Congressman Carter will provide an update on what is currently happening in the United States Congress. You won't want to miss this exciting session. Register TODAY, here.  

Registration advance discount pricing ends on or before May 1, 2017.

Reserve your hotel room on or before Thursday, May 18, 2017 to receive the IACP group rate.  See you in D.C.!
Stay Up with Your State Legislative and Regulatory News

Exclusive Member Benefit: New  Compounders Stateside Comprehensive Legislative and Regulation updates have been posted for you on IACP's website! Click here to view.
Help Keep Compounding Front & Center!

IACP is making real progress through our DQSA Coalition as well as your efforts in educating your respective congressional representatives. We have a lot more before us!  Please help us maintain the momentum by contributing today . Your support will allow us to represent your pharmacy's and your patients' issues!
Corporate Partner Spotlight:  Kunesa LLC

The Best Strategies to Increase Front-end Sales in a Compounding Pharmacy

Why is it essential to increase front-end sales?
Because of the long-term trends of:

* Eroding Rx margins 
* Increasing expenditures for health/wellness/nutrition.

In addition:

* Front-end margins are not controlled by any government agency
* Their average gross margin are ca. 40%-50%
* There is an increasing reliance on self-care
* The FDA is continuously approving Rx/OTC switches.

In pharmacy chains the ratio of Rx to front-end sales is about 50/50.

IACP is Building a New Advocacy Site - We Need Your Help

IACP is building a new advocacy program & website for Partnership for Personalized Prescriptions (P3) with a launch date next month! 

WE NEED YOUR HELP! We're looking for pharmacy compounding patient/practitioner testimonials, photos, videos, and editorial topics for a P3 newsletter that will be distributed to more than 150,000 P3 advocates!

This effort will only be successful if we can get our members behind our efforts. Please forward any story ideas, testimonials, photos, videos, etc. to IACP's VP of Communications Dagmar Anderson at

Keep the Ideas Coming - email Dagmar or call IACP at 281/933-8400.

IACP Member News

Becca Mitchell, PharmD, FIACP, VP Regulatory & Quality, US Compounding Pharmacy, Conway, Ark., is running for the Arkansas State Board of Pharmacy "I believe it's important with USP <800> coming and FDA's overreach that the Arkansas Board has someone who knows compounding and understands the nuances of the industry, and will advocate for practical, patient-focused regulations that balance access and quality."

David Rochefort, RPh, owner of Eastern States Compounding Pharmacy in Littleton, N.H., is working with local lawmakers on bill to stop big corporations from charging N.H. pharmacies tens of thousands of dollars to sell their products. Click here to read more.

IACP Corporate Partner News

LP3 Network Opens State-of-the-Art Learning Facility in Aventura, Fla.

LP3 Network is proud to announce the opening of their new state-of-the-art Learning Facility in Aventura, Florida! To learn more,  please click here

IACP Welcomes New Corporate Partner: FLACKTEK, INC.

To learn more about FlackTek, Inc., please visit

Need CE, ASAP?

If you need CE credit, check out IACP AdvanCE's on-demand library. The library houses more than 100 programs on a variety of pharmacy topics. Please click here to access the self-paced programs.

Featured Webinar Programs:

Compounding Pharmacy Enforcement Update: Nationwide Increase in Civil and Criminal Investigations

Upcoming IACP and IACP Foundation Events!

Save the Date!

Register Today! Registration Advance Discount Pricing Ends On or Before Monday, May 1, 2017

IACP| 281.933.8400 | |

(C) IACP 2017